Citigroup provided market analysis on HealthEquity (HQY) stock on July 9, 2026.
Steady: 0 in the last 7 days
Updated oct 14
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided market analysis on HealthEquity (HQY) stock on July 9, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup reaffirmed its market outperform rating for HealthEquity stock.1 source
- Citigroup reaffirmed a market outperform rating for HealthEquity.Sub-event
Citigroup released market analysis on HealthEquity (HQY) stock.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
HealthEquity
healthcare Company
Nothing else this week.
Related events
- Citigroup issued a market underperform rating for Hovnanian Enterprises, Inc. on October 22, 2026.
- Privia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup increased its price objective on Oceaneering International stock, while MarketBeat reported the consensus rating.
- Multiple financial firms issued rating changes, target price adjustments, and acquired stakes in Capital Southwest Corporation.